Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

CN 1

Next Previous
X
Search
Drug Profile

CN 1

Alternative Names: CN-1

Latest Information Update: 28 Aug 2023

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Curon Biopharmaceutical (Australia) Co Pty Ltd
  • Class Antineoplastics; Immunotherapies
  • Mechanism of Action CD4-positive T-lymphocyte stimulants; CD8 positive T lymphocyte stimulants; Cytokine stimulants; Regulatory T-lymphocyte modulators; T lymphocyte stimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Phase I/II Lymphoma
  • No development reported B-cell lymphoma; Solid tumours

Most Recent Events

  • 28 Aug 2023 No recent reports of development identified for phase-I development in B-cell lymphoma(Late-stage disease, Second-line therapy or greater) in Austria (IV, Infusion)
  • 28 Aug 2023 No recent reports of development identified for phase-I development in Solid-tumours(Late-stage disease, Second-line therapy or greater) in Austria (IV, Infusion)
  • 20 Oct 2022 Curon Biopharmaceutical (Australia) Co Pty Ltd terminates a phase I/II trial in Lymphoma (Combination therapy, Second-line therapy or greater) in Australia (PO) as the sponsor decided that there was no benefit in the drug treatment and due to company change in landscape in the new year (NCT04880564)

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top